Greater reductions in plasma aldosterone with aliskiren in hypertensive patients with higher soluble (Pro)renin receptor level

被引:11
作者
Bokuda, Kanako [1 ]
Morimoto, Satoshi [1 ]
Seki, Yasufumi [1 ]
Yatabe, Midori [1 ]
Watanabe, Daisuke [1 ]
Yatabe, Junichi [1 ]
Ando, Takashi [1 ]
Shimizu, Satoru [2 ]
Itoh, Hiroshi [3 ]
Ichihara, Atsuhiro
机构
[1] Tokyo Womens Med Univ, Dept Med Endocrinol & Hypertens 2, Tokyo, Japan
[2] Tokyo Womens Med Univ, Dept Med Educ, Tokyo, Japan
[3] Keio Univ, Sch Med, Dept Endocrinol Metab & Nephrol, Tokyo, Japan
关键词
ANKLE VASCULAR INDEX; STAGE RENAL-DISEASE; PRO RENIN RECEPTOR; BLOOD-PRESSURE; ARTERIAL STIFFNESS; HEART-FAILURE; PREGNANCY; ALBUMINURIA; EXPRESSION; PREDICTION;
D O I
10.1038/s41440-018-0037-1
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The (pro)renin receptor is important in the regulation of the tissue renin-angiotensin-aldosterone system. The benefits and safety of single-aliskiren treatment without other renin-angiotensin-aldosterone system inhibitors remain unclear. The serum level of the soluble form of the (pro)renin receptor is thought to be a biomarker reflecting the activity of the tissue renin-angiotensin-aldosterone system. We investigated the effects of single renin-angiotensin-aldosterone system blockade with aliskiren on renal and vascular functions and determined if serum level of the soluble (pro)renin receptor was a predictor of aliskiren efficacy in hypertensive patients with chronic kidney disease. Thirty-nine essential hypertensive patients with chronic kidney disease in our outpatient clinic were randomly assigned to receive either aliskiren or amlodipine. The parameters associated with renal and vascular functions and indices of renin-angiotensin-aldosterone system components, including serum levels of the soluble form, were evaluated before and after 12-week and 24-week treatment. Blood pressure was not significantly different between the groups. No significant changes in serum levels were observed in the soluble (pro) renin receptor in either group. Urinary albumin, protein excretion, and cardio-ankle vascular index significantly decreased in the aliskiren group. In the aliskiren group, there was a significant negative correlation between the basal level of the soluble (pro)renin receptor and the change in plasma aldosterone concentration. Single renin-angiotensin-aldosterone system blockade with aliskiren showed renal and vascular protective effects independent of blood pressure reduction. Serum levels of the soluble (pro)renin receptor may indicate aldosterone production via the (pro)renin receptor in the adrenal gland.
引用
收藏
页码:435 / 443
页数:9
相关论文
共 30 条
[1]   Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria [J].
Abe, Masanori ;
Maruyama, Noriaki ;
Suzuki, Hiroko ;
Fujii, Yuki ;
Ito, Midori ;
Yoshida, Yoshinori ;
Okada, Kazuyoshi ;
Soma, Masayoshi .
HYPERTENSION RESEARCH, 2012, 35 (08) :874-881
[2]   Serum Soluble (Pro)Renin Receptor Levels in Maintenance Hemodialysis Patients [J].
Amari, Yoshifumi ;
Morimoto, Satoshi ;
Nakajima, Fumitaka ;
Ando, Takashi ;
Ichihara, Atsuhiro .
PLOS ONE, 2016, 11 (07)
[3]  
Bonakdaran S, 2017, CURR DIABETES REV, V13, P555, DOI 10.2174/1573399812666160919100253
[4]   Elevated blood pressure and heart rate in human renin receptor transgenic rats [J].
Burcklé, CA ;
Danser, AHJ ;
Müller, DN ;
Garrelds, IM ;
Gasc, JM ;
Popova, E ;
Plehm, R ;
Peters, J ;
Bader, M ;
Nguyen, G .
HYPERTENSION, 2006, 47 (03) :552-556
[5]   Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats [J].
Feldman, David L. ;
Jin, Liang ;
Xuan, Hong ;
Contrepas, Aurelie ;
Zhou, Yinong ;
Webb, Randy L. ;
Mueller, Dominik N. ;
Feldt, Sandra ;
Cumin, Frederick ;
Maniara, Wieslawa ;
Persohn, Elke ;
Schuetz, Helmut ;
Danser, A. H. Jan ;
Nguyen, Genevieve .
HYPERTENSION, 2008, 52 (01) :130-136
[6]   Central aortic blood pressure and augmentation index during normal pregnancy [J].
Fujime, Mika ;
Tomimatsu, Takuji ;
Okaue, Yuko ;
Koyama, Shinsuke ;
Kanagawa, Takeshi ;
Taniguchi, Takeshi ;
Kimura, Tadashi .
HYPERTENSION RESEARCH, 2012, 35 (06) :633-638
[7]   Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure The ASTRONAUT Randomized Trial [J].
Gheorghiade, Mihai ;
Boehm, Michael ;
Greene, Stephen J. ;
Fonarow, Gregg C. ;
Lewis, Eldrin F. ;
Zannad, Faiez ;
Solomon, Scott D. ;
Baschiera, Fabio ;
Botha, Jaco ;
Hua, Tsushung A. ;
Gimpelewicz, Claudio R. ;
Jaumont, Xavier ;
Lesogor, Anastasia ;
Maggioni, Aldo P. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (11) :1125-1135
[8]   Increased expression of (pro)renin receptor in the remnant kidneys of 5/6 nephrectomized rats [J].
Hirose, Takuo ;
Mori, Nobuyoshi ;
Totsune, Kazuhito ;
Morimoto, Ryo ;
Maejima, Takahiro ;
Kawamura, Takuya ;
Metoki, Hirohito ;
Asayama, Kei ;
Kikuya, Masahiro ;
Ohkubo, Takayoshi ;
Kohzuki, Masahiro ;
Takahashi, Kazuhiro ;
Imai, Yutaka .
REGULATORY PEPTIDES, 2010, 159 (1-3) :93-99
[9]   Association of (Pro)renin Receptor Gene Polymorphism With Blood Pressure in Japanese Men: The Ohasama Study [J].
Hirose, Takuo ;
Hashimoto, Masahiro ;
Totsune, Kazuhito ;
Metoki, Hirohito ;
Asayama, Kei ;
Kikuya, Masahiro ;
Sugimoto, Ken ;
Katsuya, Tomohiro ;
Ohkubo, Takayoshi ;
Hashimoto, Junichiro ;
Rakugi, Hiromi ;
Takahashi, Kazuhiro ;
Imai, Yutaka .
AMERICAN JOURNAL OF HYPERTENSION, 2009, 22 (03) :294-299
[10]   Urinary Angiotensinogen as a Novel Biomarker of the Intrarenal Renin-Angiotensin System Status in Hypertensive Patients [J].
Kobori, Hiroyuki ;
Alper, A. Brent, Jr. ;
Shenava, Rajesh ;
Katsurada, Akemi ;
Saito, Toshie ;
Ohashi, Naro ;
Urushihara, Maki ;
Miyata, Kayoko ;
Satou, Ryousuke ;
Hamm, L. Lee ;
Navar, L. Gabriel .
HYPERTENSION, 2009, 53 (02) :344-U407